Torrent Pharmaceuticals Ltd (TORNTPHARM)

Torrent Pharmaceuticals Ltd (TORNTPHARM) is listed on the NSE in the Pharmaceuticals sector, Pharmaceuticals & Biotechnology industry. Market capitalisation: 164822.93 Cr. Figures below are as reported and are shown with their source and date.

Educational use only — GoQuant is a research tool. This page lists company facts only and is not a recommendation. Investment advice is provided by FINOME TECHNOLOGIES PVT LTD (AltQube), SEBI-registered Investment Adviser, registration no. INA000018373, under a signed advisory agreement and after a risk profile. Past performance is not indicative of future results.

Company profile

Sector
Pharmaceuticals
Industry
Pharmaceuticals & Biotechnology
Market cap (₹ Cr)
1,64,822.93

Torrent Pharmaceuticals Ltd. engages in the research, development, manufacture, and marketing of generic pharmaceutical formulations. The company is headquartered in Ahmedabad, Gujarat and currently employs 13,573 full-time employees. The firm is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain, gynecology, and dermatology. The firm is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its acne/facecare products brands include Clinmiskin, ACNEMOIST, TRACNILO and fash. The firm's hair/scalp care products brands include Proanagen, Perlice, Permite and NOSKURF. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim. The firm's primary channel of distribution is through the wholesale drug distributors, stockiest and retail pharmacies.

Source: finedge · as of 2026-09-29

Price, last year

Last close (₹): 4,615.3

Source: quantro_screener_metrics_job · as of 2026-10-22

Key figures

P/E
72.22
52-week high
5,250
52-week low
3,494
Revenue CAGR, 3 years (%)
13.27
Revenue CAGR, 5 years (%)
11.8
EPS CAGR, 3 years (%)
20.21
EPS CAGR, 5 years (%)
11.56

Source: quantro_screener_metrics_job · as of 2026-10-23

Annual summary

Year endedRevenue (₹ Cr)PAT (₹ Cr)EPS (₹)
Mar 202613,9802,16363.91
Mar 202511,5161,91156.46
Mar 202410,7281,65648.93
Mar 20239,6201,24536.79
Mar 20228,50877722.96

Source: finedge · as of 2026-07-21

Shareholding and promoter pledge

Promoter
68.31%
FII
16.18%
DII
9.06%
Public
6.45%
Promoter shares pledged
0%

Source: finedge · as of 2026-03-31

Similar companies

Source: quantro_company_profiles · as of 2026-10-23

Recent exchange filings

Source: nse · as of 2026-10-05

Frequently asked questions

What does Torrent Pharmaceuticals Ltd do?
Torrent Pharmaceuticals Ltd. engages in the research, development, manufacture, and marketing of generic pharmaceutical formulations. The company is headquartered in Ahmedabad, Gujarat and currently employs 13,573 full-time employees. The firm is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain, gynecology, and dermatology. The firm is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its acne/facecare products brands include Clinmiskin, ACNEMOIST, TRACNILO and fash. The firm's hair/scalp care products brands include Proanagen, Perlice, Permite and NOSKURF. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim. The firm's primary channel of distribution is through the wholesale drug distributors, stockiest and retail pharmacies.
Which sector is Torrent Pharmaceuticals Ltd in?
Torrent Pharmaceuticals Ltd is in the Pharmaceuticals sector, Pharmaceuticals & Biotechnology industry.
What are Torrent Pharmaceuticals Ltd's latest annual revenue and profit?
For the year ended Mar 2026: revenue 13980.00 Cr, profit after tax 2163.00 Cr.
What is the promoter holding and pledge in Torrent Pharmaceuticals Ltd?
Promoter holding is 68.31%; pledged shares are 0.00% of the promoter holding.
Which companies are similar to Torrent Pharmaceuticals Ltd?
Companies in the same sector of similar size: Zydus Lifesciences Ltd, Cipla Ltd, Lupin Ltd, Mankind Pharma Ltd, Divi's Laboratories Ltd, Dr Reddy's Laboratories Ltd.
Want more history and detail? Create a free account for the full price history, quarterly statements, balance sheet and cash flow.

Figures computed 2026-10-23.